Search clinical trials for: Synergy DES Implantation during coronary angioplasty

Total 31 results

Cardionovum GmbH
Mediolanum Cardio Research

Completed

XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization (XLIMIT)

Coronary Artery Disease

Spain, Italy
Fondazione Evidence per Attività e Ricerche Cardiovascolari...
Mediolanum Cardio Research

Completed

Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES

Coronary Artery Disease | Diabetes

Italy
Instituto Dante Pazzanese de Cardiologia

Recruiting

Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility

Percutaneous Coronary Intervention | Myocardial Dysfunction | STEMI - ST Elevation Myocardial Infarction

Brazil
Nanjing First Hospital, Nanjing Medical University

Completed

Intravascular Ultrasound Guided Drug Eluting Stents Implantation in "All-comers" Coronary Lesions （ULTIMATE Trial） (ULTIMATE)

Coronary Artery Disease

China
Poznan University of Medical Sciences

Completed

Complex CAD Treated With PCI With DES Implantation.

Complex Coronary Artery Disease

Poland
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Yonsei University

Completed

Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial

Coronary Artery Disease

Korea, Republic of
Hospital Universitari Vall d'Hebron Research Institute

Unknown

BiOSS Study (BiOSS LIM C Stent Registry in Bifurcated Lesions) (BIOSS)

Coronary Artery Disease

Spain
North Karelia Central Hospital
Turku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaborators

Recruiting

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)

Coronary Artery Disease

Finland, France, Germany, United Kingdom
Federico II University
AdvicePharma Group

Active, not recruiting

Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES (PARTHENOPE)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Chronic Coronary Syndrome

Italy
Mayo Clinic
NaviNetics Inc.

Withdrawn

New Stereotactic Frame System for Neurosurgery

Parkinson Disease | Obsessive-Compulsive Disorder | Dystonia | Essential Tremor | Tourette Syndrome
Samsung Medical Center
Genoss Company Limited, Suwon, Korea

Recruiting

GENOSS Coronary Stent Clinical Trial

Ischemic Heart Disease

Korea, Republic of
SIS Medical AG

Suspended

Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR (AbsorbISR)

Coronary Artery Disease | Coronary Restenosis

Switzerland
Meshalkin Research Institute of Pathology of Circulation

Completed

Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE (PATRIOT)

Coronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery Stenosis

Russian Federation
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)

In-Stent Restenosis

Spain
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Azienda Ospedaliero Universitaria Maggiore della...

Unknown

Novara Registry of Platinum-Chromium Platform Stents (PROMETEUS)

Myocardial Infarction | External Causes of Morbidity and Mortality | Fracture of Stent of Coronary Artery | Coronary Vessel Disorders

Italy
University of Nottingham

Completed

Effects of Bolus and Continuous Nasogastric Feeding on Small Bowel Water Content and Blood Flow

Enteral Feeding | Diarrhoea | Nasogastric Feeding

United Kingdom
Central Clinical Hospital of the Ministry of Internal...
University National Heart Hospital

Completed

POLish Bifurcation Optimal Stenting Study (POLBOS)

Coronary Artery Disease

Poland
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
ECRI bv
Boston Scientific Corporation; Volcano Corporation

Completed

Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI

Heart Diseases | Cardiovascular Diseases | 3 Vessel Coronary Artery Disease

Netherlands, Poland, Spain, United Kingdom
Central Clinical Hospital of the Ministry of Internal...

Completed

DES Versus BiOSS LIM - POLBOS II Study (POLBOS II)

Coronary Artery Disease

Poland
University Hospital, Grenoble

Recruiting

Evaluation of a Strategy Guided by Imaging Versus Systematic Coronary Angiography in Elderly Patients With Ischemia (EVAOLD)

Myocardial Infarction

France
Capital Medical University
Beijing Anzhen Hospital

Completed

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

Coronary Artery Disease

China
Aalborg University Hospital

Recruiting

Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy

Type 2 Diabetes | Osteoporosis | Diabetic Neuropathy Peripheral | Bone Disease | Autonomic Neuropathy, Diabetic

Denmark
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

T Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma

United States, Canada, Australia, New Zealand, Switzerland
National Cancer Institute (NCI)

Active, not recruiting

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia

United States, Canada, Puerto Rico, Australia, New Zealand
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Adult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditions

United States, Canada, Australia, New Zealand
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

B Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

United States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
National Cancer Institute (NCI)

Recruiting

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Down Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic Lymphoma

United States, Canada, Puerto Rico, Australia, New Zealand
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute Leukemia

United States, Canada, Australia, Puerto Rico, New Zealand

Search clinical trials for: Synergy DES Implantation during coronary angioplasty

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations